Metoclopramide Injection USP — Class II drug recall D-0297-2021
Terminated recall by Teva Pharmaceuticals USA, reported 2021-03-10, distributed nationwide. Chemical contamination; Unknown brown residue adhering to the inside of one vial.
| Recall number | D-0297-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2021-02-15 |
| Classified | 2021-03-03 |
| Reported by FDA | 2021-03-10 |
| Terminated | 2021-08-26 |
| Distributed | Nationwide (US) |
| Quantity | 9,452 cartons |
| Reason classes | chemical contamination |
| NDC | 00703-4502, 00703-4502-01, 00703-4502-04 |
| Lot numbers | 31325335B |
| Expiration dates | 2021-07 |
Product
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
Reason for recall
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0297-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.